Asthma Clinical Trial
Official title:
Teaching Use of Respiratory Inhalers (TURI)
The purpose of this study is to evaluate the feasibility of enrolling and randomizing
patients into one of two educational interventions to teach appropriate respiratory inhaler
technique and to collect preliminary estimates of the comparative effectiveness of two types
of education.
Teach-to-Goal (TTG) education employs instruction followed by patient "teach-back," then
repeated cycles of learning and assessment until a skill, i.e. respiratory inhaler technique,
is mastered. By contrast, Brief Intervention (BI) education only consists of providing the
patient with verbal and written instruction on the skill, i.e., respiratory inhaler
technique.
The investigators hypothesize that hospital-based TTG compared to BI increases a patient's
ability to learn respiratory inhaler technique. The investigators will test this hypothesis
separately for the MDI and Diskus® devices.
Respiratory inhalers are often used incorrectly by hospitalized patients with asthma or
chronic obstructive pulmonary disease (COPD). As the mainstay of bronchodilator and
anti-inflammatory therapy for these patients, the implication of this difficulty with
self-management is that patients are at risk for under-treatment and worse health outcomes.
Several factors are thought to contribute to poor self-management skills, particularly
inadequate patient education at healthcare encounters and inadequate patient health literacy
(HL; ability to understand and use healthcare instructions). Inadequate HL in patients with
asthma leads to worse knowledge about medications in general and inhaler technique
specifically, and patients with inadequate HL are more likely to be hospitalized. As a
result, national and international guidelines for both asthma and COPD recommend patient
education to improve self-management skills regarding use of respiratory inhalers and
assessing patient comprehension at all points of care, including hospitals. However, the most
effective strategy to instruct patients about respiratory inhaler use in hospital settings is
unclear, particularly in populations enriched with inadequate HL.
Teach-to-goal (TTG) is a method of patient instruction that employs repeated rounds of
teaching and assessments of patient comprehension until mastery is confirmed. Our preliminary
data in hospitalized patients suggest that TTG may be a particularly powerful method to teach
this high-risk population how to use respiratory inhalers correctly, including patients with
inadequate HL. However, TTG is likely to be more resource-intensive (personnel training and
time) than approaches used in everyday clinical settings (usual care). Further, the relative
magnitude of the effectiveness of TTG compared to other less resource-intensive methods on
patient comprehension and health outcomes is not known. As healthcare resources are limited,
empiric data about the comparative effectiveness of TTG and alternate approaches of patient
education are needed.
Therefore this pilot comparative effectiveness study will compare the TTG approach versus a
brief intervention (BI) for patients hospitalized with asthma or COPD to evaluate the
feasibility of conducting a randomized clinical trial of two educational interventions in
this population and to collect preliminary estimates of the relative benefits of TTG vs. BI.
These data will help inform the design of subsequent larger studies of comparative
effectiveness.
The primary research goal is to evaluate the feasibility of conducting a randomized clinical
trial of two different strategies to teach respiratory inhaler use and to determine
preliminary estimates of effect size for the interventions; specifically, the investigators
will assess our recruitment and retention rates, pilot test case reports and other study
procedures and to evaluate the resources (staff & investigator time, costs for patient
incentives and other study materials) needed to perform the trial. These data will inform
subsequent studies by providing important information regarding feasibility, effect size for
sample calculations and preliminary data to secure funding for the development of further
research. The Specific Aims are:
Specific Aim 1: To evaluate the feasibility of enrolling and randomizing patients into an
educational intervention to teach appropriate respiratory inhaler technique.
Specific Aim 2: To obtain a preliminary estimate of the effect size of TTG vs. BI in order to
determine the necessary sample size for a larger comparative effectiveness study designed to
improve health outcomes.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|